Literature DB >> 26703189

Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.

Antonio Gomez-Muñoz1, Natalia Presa2, Ana Gomez-Larrauri3, Io-Guané Rivera4, Miguel Trueba5, Marta Ordoñez6.   

Abstract

Inflammation is a network of complex processes involving a variety of metabolic and signaling pathways aiming at healing and repairing damage tissue, or fighting infection. However, inflammation can be detrimental when it becomes out of control. Inflammatory mediators involve cytokines, bioactive lipids and lipid-derived metabolites. In particular, the simple sphingolipids ceramides, sphingosine 1-phosphate, and ceramide 1-phosphate have been widely implicated in inflammation. However, although ceramide 1-phosphate was first described as pro-inflammatory, recent studies show that it has anti-inflammatory properties when produced in specific cell types or tissues. The biological functions of ceramides and sphingosine 1-phosphate have been extensively studied. These sphingolipids have opposing effects with ceramides being potent inducers of cell cycle arrest and apoptosis, and sphingosine 1-phosphate promoting cell growth and survival. However, the biological actions of ceramide 1-phosphate have only been partially described. Ceramide 1-phosphate is mitogenic and anti-apoptotic, and more recently, it has been demonstrated to be key regulator of cell migration. Both sphingosine 1-phosphate and ceramide 1-phosphate are also implicated in tumor growth and dissemination. The present review highlights new aspects on the control of inflammation and cell migration by simple sphingolipids, with special emphasis to the role played by ceramide 1-phosphate in controlling these actions.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell migration; Ceramide 1-phosphate; Ceramides; Inflammation; Sphingolipids; Sphingosine 1-phosphate

Mesh:

Substances:

Year:  2015        PMID: 26703189     DOI: 10.1016/j.plipres.2015.09.002

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  56 in total

Review 1.  Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.

Authors:  Mitchell K P Lai; Wee Siong Chew; Federico Torta; Angad Rao; Greg L Harris; Jerold Chun; Deron R Herr
Journal:  Neuromolecular Med       Date:  2016-07-08       Impact factor: 3.843

2.  Lateral Segregation of Palmitoyl Ceramide-1-Phosphate in Simple and Complex Bilayers.

Authors:  Md Abdullah Al Sazzad; Tomokazu Yasuda; Thomas K M Nyholm; J Peter Slotte
Journal:  Biophys J       Date:  2019-05-21       Impact factor: 4.033

3.  LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages.

Authors:  Junfei Jin; Zhongyang Lu; Yanchun Li; Ji Hyun Ru; Maria F Lopes-Virella; Yan Huang
Journal:  J Leukoc Biol       Date:  2018-06-08       Impact factor: 4.962

Review 4.  Targeting Sphingosine Kinases for the Treatment of Cancer.

Authors:  Clayton S Lewis; Christina Voelkel-Johnson; Charles D Smith
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

5.  Metabolic adaptation to calorie restriction.

Authors:  Carlos Guijas; J Rafael Montenegro-Burke; Rigo Cintron-Colon; Xavier Domingo-Almenara; Manuel Sanchez-Alavez; Carlos A Aguirre; Kokila Shankar; Erica L-W Majumder; Elizabeth Billings; Bruno Conti; Gary Siuzdak
Journal:  Sci Signal       Date:  2020-09-08       Impact factor: 8.192

Review 6.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

7.  Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors.

Authors:  Samantha Caputo; Simona Di Martino; Vincenzo Cilibrasi; Piero Tardia; Marco Mazzonna; Debora Russo; Ilaria Penna; Maria Summa; Sine Mandrup Bertozzi; Natalia Realini; Natasha Margaroli; Marco Migliore; Giuliana Ottonello; Min Liu; Peter Lansbury; Andrea Armirotti; Rosalia Bertorelli; Soumya S Ray; Renato Skerlj; Rita Scarpelli
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

8.  Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.

Authors:  Michael B Dinkins; John Enasko; Caterina Hernandez; Guanghu Wang; Jina Kong; Inas Helwa; Yutao Liu; Alvin V Terry; Erhard Bieberich
Journal:  J Neurosci       Date:  2016-08-17       Impact factor: 6.167

Review 9.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

10.  Tetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate.

Authors:  Xiaoyun Tang; Yuan Y Zhao; Jay Dewald; Jonathan M Curtis; David N Brindley
Journal:  J Lipid Res       Date:  2016-02-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.